Clinical trial
Open-Label Extension of the HOPE-2 Duchenne Muscular Dystrophy Trial
NCT04428476 is registered in ClinicalTrials.gov with Capricor Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Open-Label Extension of the HOPE-2 Duchenne Muscular Dystrophy Trial
- Lead sponsor
- Capricor Inc.
- Phase
- Phase 2
- Overall status
- Active, not recruiting
- Start date
- August 5, 2020
- Completion date
- March 31, 2027
- Enrollment
- 13 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
duchenne muscular dystrophy